Cellyan Biotechnology Co., Ltd - HKPD
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| StoneX Group Inc. | History | Added to | 102,310 | 52 | 0.0% | 0.0% | 1 | +62,915 | 159.7% | Q2 2026 | Aug 12, 2026 |
| JANE STREET GROUP, LLC | History | New | 49,087 | 18 | 0.0% | — | 2 | +49,087 | New | Q2 2026 | Aug 14, 2026 |
| HRT FINANCIAL LP | History | New | 41,824 | 15 | 0.0% | — | 3 | +41,824 | New | Q2 2026 | Aug 14, 2026 |
| XTX Topco Ltd | History | New | 38,930 | 14 | 0.0% | — | 4 | +38,930 | New | Q2 2026 | Aug 14, 2026 |
| Clear Street Group Inc. | History | No change | 12,019 | 4 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q2 2026 | Aug 12, 2026 |
| TWO SIGMA INVESTMENTS, LP | History | Closed out | 0 | 0 | — | 0.0% | — | -10,832 | -100.0% | Q2 2026 | Aug 14, 2026 |
| UBS Group AG | History | Added to | 1,081 | 0 | — | — | — | +971 | 882.73% | Q2 2026 | Aug 13, 2026 |